Corporate Report: March 22


  • By
  • | 7:51 a.m. March 22, 2013
  • Strategies
  • Share

NeoGenomics selling 3 million shares, sets price to generate $7.8 million
NeoGenomics Inc., a Fort Myers-based cancer-focused genetic testing service, has priced a public offering of 3.15 million shares of common stock at $3 per share. The company plans to sell 2.85 million shares and The Mary S. Dent Gifting Trust will sell another 300,000 NeoGenomics shares.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content